Doctor profile · Federal record
Dr. Tristan Bice, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Vancouver, WA
- NPI 1912369190
- Accepts Medicare
- 10 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
210 Se 136Th Ave
Vancouver, WA 986846930
(360) 944-9889 - Additional location
-
1740 W Taylor St
Chicago, IL 606127232
(866) 600-2273 - Mailing address
-
1498 Se Tech Center Pl Ste 240
Vancouver, WA 986835508
Credentials & registration
- NPI registered
- March 2016 — 10 yrs on file
- Profile last updated
- May 1, 2025
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Washington #MD61271493 · Oregon #MD209944
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1912369190. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
39,213
Distinct HCPCS
10
Medicare allowed
$761,430
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1453 |
Injection, fosaprepitant, 1 mg | 8,100 | 30 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,801 | 17 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,865 | 21 | $3 | |
J9267 |
Injection, paclitaxel, 1 mg | 4,974 | 13 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,908 | 37 | $0 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,340 | 12 | $29 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 720 | 33 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 600 | 33 | $1 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 480 | 20 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 449 | 117 | $8 |
In context: peer comparison
Among 5 peers in Vancouver Hematology & Oncology Physician, average services per provider: 460. This provider delivers 85× the peer median.Open Payments
Industry payments received
All-time total
$764
Transactions
10
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma US INC | 2 | $199.98 | |
| Boston Scientific Corporation | 3 | $159.70 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $131.25 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $95.48 | |
| Sanofi-Aventis U.S. LLC | 1 | $84.75 | |
| Aveo Pharmaceuticals, INC. | 1 | $74.99 | |
| Merck Sharp & Dohme LLC | 1 | $18.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
421
Patients
83
Total drug cost
$815,998
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 91 | 24 | $505 |
| Abiraterone Acetate | Generic | 57 | 11 | $56,278 |
| Dexamethasone | Generic | 44 | 13 | $661 |
| Calquence (Acalabrutinib Maleate) | Brand | 36 | 0 | $526,124 |
| Hydroxyurea | Generic | 33 | 0 | $1,030 |
| Levetiracetam | Generic | 22 | 0 | $1,661 |
| Ondansetron Odt (Ondansetron) | Brand | 20 | 12 | $653 |
| Acyclovir | Generic | 18 | 0 | $216 |
| Olanzapine | Generic | 16 | 0 | $417 |
| Oxycodone Hcl | Generic | 16 | 11 | $298 |
Frequently asked questions
What is Dr. Tristan Bice's medical specialty?
Dr. Tristan Bice practices Hematology & Oncology Physician in Vancouver, WA.
Where does Dr. Tristan Bice practice?
Dr. Tristan Bice practices at 210 Se 136Th Ave, Vancouver, WA 986846930. Office phone: 3609449889.
What is Dr. Tristan Bice's NPI?
Dr. Tristan Bice's National Provider Identifier (NPI) is 1912369190, issued by NPPES.
Does Dr. Tristan Bice accept Medicare assignment?
Yes. Dr. Tristan Bice accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tristan Bice commonly perform?
Top Medicare-reported procedures in 2023: Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.